The characteristics and impact of pruritus in adult dermatology patients: A prospective, cross-sectional study.


Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 26 05 2020
revised: 23 07 2020
accepted: 10 08 2020
pubmed: 18 8 2020
medline: 29 7 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Pruritus often accompanies chronic skin diseases, exerting considerable burden on many areas of patient functioning; this burden and the features of pruritus remain insufficiently characterized. To investigate characteristics, including localization patterns, and burden of pruritus in patients with chronic dermatoses. We recruited 800 patients with active chronic skin diseases. We assessed pruritus intensity, localization, and further characteristics. We used validated questionnaires to assess quality of life, work productivity and activity impairment, anxiety, depression, and sleep quality. Nine out of every 10 patients had experienced pruritus throughout their disease and 73% in the last 7 days. Pruritus often affected the entire body and was not restricted to skin lesions. Patients with moderate to severe pruritus reported significantly more impairment to their sleep quality and work productivity, and they were more depressed and anxious than control individuals and patients with mild or no pruritus. Suicidal ideations were highly prevalent in patients with chronic pruritus (18.5%) and atopic dermatitis (11.8%). Pruritus prevalence and intensity are very high across all dermatoses studied; intensity is linked to impairment in many areas of daily functioning. Effective treatment strategies are urgently required to treat pruritus and the underlying skin disease.

Sections du résumé

BACKGROUND BACKGROUND
Pruritus often accompanies chronic skin diseases, exerting considerable burden on many areas of patient functioning; this burden and the features of pruritus remain insufficiently characterized.
OBJECTIVE OBJECTIVE
To investigate characteristics, including localization patterns, and burden of pruritus in patients with chronic dermatoses.
METHODS METHODS
We recruited 800 patients with active chronic skin diseases. We assessed pruritus intensity, localization, and further characteristics. We used validated questionnaires to assess quality of life, work productivity and activity impairment, anxiety, depression, and sleep quality.
RESULTS RESULTS
Nine out of every 10 patients had experienced pruritus throughout their disease and 73% in the last 7 days. Pruritus often affected the entire body and was not restricted to skin lesions. Patients with moderate to severe pruritus reported significantly more impairment to their sleep quality and work productivity, and they were more depressed and anxious than control individuals and patients with mild or no pruritus. Suicidal ideations were highly prevalent in patients with chronic pruritus (18.5%) and atopic dermatitis (11.8%).
CONCLUSIONS CONCLUSIONS
Pruritus prevalence and intensity are very high across all dermatoses studied; intensity is linked to impairment in many areas of daily functioning. Effective treatment strategies are urgently required to treat pruritus and the underlying skin disease.

Identifiants

pubmed: 32798581
pii: S0190-9622(20)32426-9
doi: 10.1016/j.jaad.2020.08.035
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-700

Informations de copyright

Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Tomasz Hawro (T)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Katarzyna Przybyłowicz (K)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Max Spindler (M)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Marlena Hawro (M)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Michał Steć (M)

Department of Computer Science, University of Potsdam, Potsdam, Germany.

Sabine Altrichter (S)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Karsten Weller (K)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Markus Magerl (M)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Ulrich Reidel (U)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Ezzat Alarbeed (E)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Ola Alraboni (O)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Marcus Maurer (M)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: marcus.maurer@charite.de.

Martin Metz (M)

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH